Interestingly, DPYSL2 was also classified as one of 12 genes significantly associated with the prognosis of bladder cancer patients, and its high expression is associated with a favorable prognosis in bladder cancer patients [42]. This evidence concerns the gene DPYSL2 and urinary bladder carcinoma.